| Date | Title | Description |
| 03.03.2025 | Needle raises €2 million to access valuable information ‘locked away’ with AI | Berlin-based Needle, an AI-powered search and agent development platform, has raised €2 million Seed funding to expand their engineering team, strengthen its core technology, and accelerate its go-to-market initiatives.
The round was led by... |
| 03.03.2025 | Needle secures $2.2M Seed for AI data search and agent development | Information discovery and workflow automation startup Needle has secured $2.2 million Seed funding to help organisations unlock the potential of AI through its data search and agent development platform.
Valuable information is locked away ... |
| 05.03.2024 | Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform | - |
| 11.11.2021 | Notable Labs Launches by Acquiring Rights to Volasertib – Will Use Data, AI to Fast-Track Cancer Treatment | Thomas Bock, M.D., Chief Executive Officer of Notable
What You Should Know:
– Coming out of stealth, Notable Labs, a pioneer and developer of predictive precision medicines, is acquiring worldwide development and commercial rights to volase... |
| 23.01.2020 | Notable Launches Observational Clinical Trial for Patients with Blood Cancer | – Notable launches The ANSWer Study, it’s new observational clinical trial for patients with blood cancer and is currently enrolling patients.
– The primary assessment is to establish a tumor registry with annotated clinical outcomes.
Notab... |
| 14.10.2019 | When will robots be our doctors? | Hear from Data Collective, Doctor on Demand, Notable Labs, Evidation Health, IDx, Startup Health
Vator, HP and UCSF Health Hub held their third salon of 2019 called Reinventing the doctor, where entrepreneurs and investors from Doctor on De... |
| 19.09.2019 | Where healthtech tools fall short of satisfying patients | Kaiser Ventures, Evidation Health, Doctor on Demand, Express Care weigh in
Doctors and VCs took a deep dive during a discussion about the role technology plays in the life of the doctor, and if their lives are actually becoming better becau... |
| 11.09.2019 | At #InventHealth: when will robots become our doctors? | Executives from Doctor On Demand, Notable Labs and Evidation Health will be joining us on 9/12
This week, Vator, with partners HP and UCSF Health Hub, will host our September 12 salon focused on "Reinventing the doctor," where we ... |
| 22.07.2019 | Personalized Oncology Company Notable Announces $40 Million Funding Round | Notable — a company redefining cancer treatment with a clinically validated platform — announced it raised $40 million in Series B
Notable — a company that is redefining cancer treatment with a clinically validated platform that rapidly adv... |
| 17.07.2019 | Notable Nabs $40M to Expand Drug Discovery Platform for Personalized Oncology | Notable, a San Francisco, CA-based company redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development has raised $40M in Series B funding. The Series B round is co-led by B Capital Group a... |
| 16.07.2019 | Personalized cancer treatment startup Notable Labs nabs $40M Series B | Notable’s automated lab testing technology uses patient cell samples to more quickly understand the effect of specific cancer treatments on individuals, thereby boosting the efficiency and speed of drug development efforts.
B Capital Group ... |
| 16.07.2019 | Notable Raises $40M in Series B Funding | Notable, a Foster City, California-based developer of a clinically validated platform that advances cancer drug development, raised $40M in Series B funding.
The round, which brings total funding to over $55M, was co-led by B Capital Group ... |
| 16.07.2019 | Notable raises $40 million to personalize cancer drug regimens | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Update: Notable has raised $40 million, not the $... |
| 16.07.2019 | Notable Labs Scores $40M Series B Round |
SAN FRANCISCO, CA, Notable Labs has announced a $40 million Series B round.
>> Click here for more funding data on Notable Labs
>> To export Notable Labs funding data to PDF and Excel, click here
Notable, which is redefin... |
| 16.07.2019 | Notable raises $40 million to personalize cancer drug regimens | Update: Notable has raised $40 million, not the $50 million suggested by the original headline.
Notable Labs, a Foster City, California-based provider of personalized drug combination testing for cancer patients, today revealed that it’s cl... |
| 16.07.2019 | AI-focused Notable Labs score $40M in funding; Seattle Genetics/Astellas submit marketing application for enfortumab vedotin | → The AI experts at Notable Labs have garnered another $40 million to scale their automated laboratory and analytics platform. Designed to match patients to clinical trials by predicting quickly who are most likely... |
| 15.05.2019 | With new cancer drugs, the challenge is finding where cost, value meet | “It’s something that we’ve always struggled with,” Tada said in a phone interview, referring to the question of value versus cost.
For example, compared with the US, drugmakers can charge whatever they want to, which works well for their bo... |
| 09.05.2019 | Don’t miss this innovation in cancer treatment conference in Philadelphia | A panel discussion will explore how precision medicine can be the key to population health. Experts from Cancer Treatment Centers of America, Color and other organizations will talk about the synergies between precision medicine and populat... |
| 15.04.2019 | Stanford, Notable Labs and Tempus collaborate on personalized medicine research for blood cancer | The study – which was focused on MDS cancer patients who had unsuccessfully undergone the standard of care for their disease – was an attempt to create personalized recommendations about what other potential treatment options may work.
Rese... |
| 22.01.2019 | Silicon Valley startup launches first drug development program with novel nonprofit partnership | “We’re focusing more around taking a drug that either already been in trials, that’s a generic or is a natural product and then really making sure that that gets given to the right patient by testing their samples beforehand,” Notable Labs ... |
| 06.09.2018 | Wearable, voice-powered doctor's assistant Notable raises $13.5M | |
| 17.05.2018 | In the next few weeks, you can spend time with any one of these VCs and it will all go to charity | Five years ago, we told you about a venture capital auction wherein dozens of VCs donated their time toward a greater good — helping fund research at the Leukemia & Lymphoma Society, one of the world’s largest voluntary health organizat... |
| 07.09.2017 | Notable Labs Secures $10M Series A Funding |
SAN FRANCISCO, CA, Notable Labs today announced the closing of a $10 million Series A financing.
>> Click here for more funding data on Notable Labs
>> To export Notable Labs funding data to PDF and Excel, click here
Nota... |
| 06.09.2017 | Term Sheet — Wednesday, September 6 | SHOPPING SPREE
Good morning, Term Sheet readers.
Paid Content What you need to know about growing cyberattacks From ExtraHop
The deal, which is pending approval from the NBA Board of Governors, began in July. Fertitta who has been a lifelon... |
| 06.09.2017 | Notable Labs raises $10M for drug testing service to develop therapeutic index for oncologists | Builders VC led the Series A with support from existing investors First Round Capital, First Round Capital, Founder’s Fund, Eleven Two Capital and other investors. Y Combinator is also a backer — Notable Labs took part in its winter 2015 co... |
| 06.09.2017 | Notable Labs Raises $10M in Series A Financing | Notable Labs, a San Francisco, CA-based mission-driven company focused on advancing personalized cancer treatments, closed a $10m Series A financing.
The round was led by Builders VC, with participation from existing investors. In conjuncti... |
| 22.03.2016 | David Lee is back with a new fund: Refactor Capital | David Lee, a former Google executive who for several years ran the seed-stage venture fund SV Angel, is back with his own new firm, shows an SEC filing. The outfit is called Refactor Capital and it’s apparently targeting $50 million for its... |
| 18.11.2015 | How Scientists Can Thrive in the Startup World | When Dave Messina entered a graduate program for genomics in 1998, he was elated. He was taking the first steps of what could be a career at a top-tier university, working on scientific research that could impact millions of lives.
But whi... |
| 21.07.2015 | Y Combinator-Backed Ixchel Predicts How Cancer Drugs Will Behave In Humans Before You Even Swallow A Pill | Biotech startup Ixchel Scientific hopes to bring higher success rates to trialed cancer drugs using an environment that better represents the human body.
The YC-backed startup does this by taking cancer cells that would normally be tested i... |
| 06.05.2015 | Все стартапы последнего выпуска Y Combinator, ФРИИ, Techstars и Tolstoy Startup Camp Статьи редакции | Редакция ЦП собрала в одном материале все стартапы, которые были представлены на последнем Demo Day стартап-акселераторов Y Combinator, ФРИИ, Techstars и Tolstoy Startup Camp.
Y Combinator
Выпуск — март 2015 года.
Akido Labs — стандартизиро... |
| 25.03.2015 | The Top 10 Startups Of Y Combinator Winter ’15 Demo Day 2 | Y Combinator unveiled one of its most impressive startup batches to date yesterday, featuring big ideas in medicine, finance, and marketplaces. After carefully watching the demos, speaking with founders in the class, and querying prestigiou... |
| 24.03.2015 | 47 Startups That Launched At Y Combinator Winter 2015 Demo Day 2 | Y Combinator got so big, it had to split its Demo Day in two. During today’s second wave we saw a variety of promising biotech, marketplace, enterprise, and financial tech startups. Yesterday we chronicled 50 consumer, B2B, developer, and h... |
| 11.03.2015 | Notable Labs (YC W15) Provides Personalized Medical Testing For Brain Cancer Patients | Notable Labs joins the YC W15 batch:
“Matt de Silva was working as a hedge fund manager with Thiel Capital in the fall of 2013 when he got the news that his dad had brain cancer — specifically, a Glioblastoma multiforme, an aggressive form... |
| 10.03.2015 | YC-Backed Notable Labs Provides Personalized Medical Testing For Brain Cancer Patients | Matt De Silva was working as a hedge fund manager with Thiel Capital in the fall of 2013 when he got the news that his dad had brain cancer — specifically, a Glioblastoma multiforme, an aggressive form of brain cancer.
There are very few tr... |
| - | Personalized cancer treatment startup Notable Labs nabs $40M Series B | Silicon Valley startup Notable Labs, which uses AI to predict effective cancer treatments for patients, has raised a $40 million Series B round as it looks to to kick off a larger national and international expansion.
The financing round wa... |
| - | Stanford, Notable Labs and Tempus collaborate on personalized medicine research for blood cancer | The future of personalized cancer treatments will be enabled by technology to understand the genetic variants of a person’s disease, as well as tools to determine the best treatment pathways for the individual.
A new feasibility study from ... |
| - | Silicon Valley startup launches first drug development program with novel nonprofit partnership | Foster City, California-based Notable Labs – known for its automated research system for personalized drug testing – has launched its first drug development program targeting pediatric leukemia and is relying on a nonprofit partner to help ... |
| - | With new cancer drugs, the challenge is finding where cost, value meet | In the last two decades, numerous new drugs have come to market and turned some cancers that used to be death sentences into manageable or even curable diseases. But one significant hurdle remains: They’re often incredibly expensive. So the... |
| - | How Scientists Can Thrive in the Startup World | When Dave Messina entered a graduate program for genomics in 1998, he was elated. He was taking the first steps of what could be a career at a top-tier university, working on scientific research that could impact millions of lives.
But whi... |
| - | Notable Labs raises $10M for drug testing service to develop therapeutic index for oncologists | Notable Labs, a medtech startup cofounded by former hedge fund manager Matthew De Silva after his father developed brain cancer, has closed a $10 million Series A round. The funding will be used to support clinical trials for the developmen... |
| - | Don’t miss this innovation in cancer treatment conference in Philadelphia | It feels like we’re on the cusp of great things in the development of cancer treatments. A wave of immunotherapy and gene therapy approvals could point the way forward in treating and curing certain forms of cancer. Pharma and technology co... |
